Together we can:
We are contributing to the NHS England consultation on the NHS Ten Year Plan to help make this vision a reality. In doing so, we are building on thriving agreements already in place between our industry, the NHS and other system partners:
We are also supporting Health Data Research UK and the NHS in the establishment of digital innovation hubs that will improve the speed and efficiency of clinical studies, and allow the evaluation of innovative treatments on care pathways, as recommended in the Life Sciences Industrial Strategy.
We understand the importance of promoting careers in life sciences, as they benefit not just industry, but academia and the NHS. To inform development of our work on careers and skills needs, we draw on our biennial skills gap analysis, our most recent report being Bridging the Skills Gap. We are also a founding member of the Clinical Pharmacology Skills Alliance, which aims to develop and support a long-term, cross-sector action plan for clinical pharmacology.
17 Sep 2019
New partnership to tackle Birmingham’s biggest health challenges
A new collaboration to tackle the biggest health challenges faced by the West Midlands’ six million residents will use real-time clinical trials and health data to speed up research and improve cancer care, maternity services, child health, obesity, and dementia.
Birmingham Health Partners (BHP)* – a strategic alliance of health organisations in the West Midlands – will team up with the Association of the British Pharmaceutical Industry (ABPI) and its members to make Birmingham a world leader in the development of precision medicines tailored to patients based on genetic, environmental, and lifestyle factors.
24 Feb 2017
New partnership set to help ‘transform’ access to medicines for patients in Greater Manchester
A unique partnership announced today by the pharmaceutical industry and Greater Manchester Health and Social Care Partnership will help the city region deliver its vision to be the safest and most effective place to receive medicines in the world – and cement its position on the global research and development map.
The collaboration, in the form of a Memorandum of Understanding, will create a Greater Manchester and Pharmaceutical Industry Partnership Group. The group will improve the use and safety of medicines and use the unique data and information capabilities of the NHS to discover, develop, and deliver new medicines and treatments for patients.
The agreement will allow Greater Manchester to explore new ways of paying for medicines based on patient outcomes - enabling the £1 billion spent on medicines in the region to be as effective as possible.
New guidance to help the NHS and the pharmaceutical industry work successfully together.
The UK Life Sciences Industrial Strategy should be required reading for every healthcare leader in the UK. It makes clear that the NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes.
This guidance has been developed by the AHSN Network and the ABPI. It sets out governance and process recommendations to enable Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs) rapidly and confidently to develop collaborations with industry partners to address local health needs.